193 related articles for article (PubMed ID: 12234023)
1. Therapy-associated solid tumors.
Travis LB
Acta Oncol; 2002; 41(4):323-33. PubMed ID: 12234023
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of second primary cancers.
Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2020-6. PubMed ID: 17057028
[TBL] [Abstract][Full Text] [Related]
3. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.
Travis LB; Rabkin CS; Brown LM; Allan JM; Alter BP; Ambrosone CB; Begg CB; Caporaso N; Chanock S; DeMichele A; Figg WD; Gospodarowicz MK; Hall EJ; Hisada M; Inskip P; Kleinerman R; Little JB; Malkin D; Ng AK; Offit K; Pui CH; Robison LL; Rothman N; Shields PG; Strong L; Taniguchi T; Tucker MA; Greene MH
J Natl Cancer Inst; 2006 Jan; 98(1):15-25. PubMed ID: 16391368
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic radiation and the potential risk of second malignancies.
Kamran SC; Berrington de Gonzalez A; Ng A; Haas-Kogan D; Viswanathan AN
Cancer; 2016 Jun; 122(12):1809-21. PubMed ID: 26950597
[TBL] [Abstract][Full Text] [Related]
5. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood.
Le Vu B; de Vathaire F; Shamsaldin A; Hawkins MM; Grimaud E; Hardiman C; Diallo I; Vassal G; Bessa E; Campbell S; Panis X; Daly-Schveitzer N; Lagrange JL; Zucker JM; Eschwège F; Chavaudra J; Lemerle J
Int J Cancer; 1998 Jul; 77(3):370-7. PubMed ID: 9663598
[TBL] [Abstract][Full Text] [Related]
7. Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.
Inskip PD; Sigurdson AJ; Veiga L; Bhatti P; Ronckers C; Rajaraman P; Boukheris H; Stovall M; Smith S; Hammond S; Henderson TO; Watt TC; Mertens AC; Leisenring W; Stratton K; Whitton J; Donaldson SS; Armstrong GT; Robison LL; Neglia JP
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):800-7. PubMed ID: 26972653
[TBL] [Abstract][Full Text] [Related]
8. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
9. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.
Travis LB; Demark Wahnefried W; Allan JM; Wood ME; Ng AK
Nat Rev Clin Oncol; 2013 May; 10(5):289-301. PubMed ID: 23529000
[TBL] [Abstract][Full Text] [Related]
10. Anticancer therapies associated with secondary cutaneous malignancies: A review of the literature.
Deutsch A; Balagula Y; McLellan BN
J Am Acad Dermatol; 2020 Nov; 83(5):1425-1433. PubMed ID: 32334055
[TBL] [Abstract][Full Text] [Related]
11. Second malignant neoplasms: assessment and strategies for risk reduction.
Wood ME; Vogel V; Ng A; Foxhall L; Goodwin P; Travis LB
J Clin Oncol; 2012 Oct; 30(30):3734-45. PubMed ID: 23008293
[TBL] [Abstract][Full Text] [Related]
12. Second primary cancers: an overview.
Ng AK; Travis LB
Hematol Oncol Clin North Am; 2008 Apr; 22(2):271-89, vii. PubMed ID: 18395150
[TBL] [Abstract][Full Text] [Related]
13. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
Tubiana M
Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
[TBL] [Abstract][Full Text] [Related]
14. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
15. Secondary lung tumors in hematological patients.
Amadori D; Ronconi S
Semin Respir Crit Care Med; 2005 Oct; 26(5):520-6. PubMed ID: 16267703
[TBL] [Abstract][Full Text] [Related]
16. [Secondary neoplasms in 5-year survivors of cancer in childhood: results of the Childhood Cancer Survivor Study].
Beck JD
Strahlenther Onkol; 2002 Mar; 178(3):167-8. PubMed ID: 11962196
[No Abstract] [Full Text] [Related]
17. Second malignancies developing after treatment for paediatric cancers.
Smee R
Australas Radiol; 1995 Nov; 39(4):335-6. PubMed ID: 8561705
[No Abstract] [Full Text] [Related]
18. Carcinogenic effects of scattered dose associated with radiation therapy.
Cumberlin RL; Dritschilo A; Mossman KL
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):623-9. PubMed ID: 2777651
[TBL] [Abstract][Full Text] [Related]
19. [Therapy-related acute leukemia: study of 23 pacients].
Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
[TBL] [Abstract][Full Text] [Related]
20. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
